Ppargtm1.1Auw |
Ppargtm1.1Auw/Ppargtm1.1Auw B6.Cg-Pparg |
MGI:97747 |
MP:0004185 |
abnormal adipocyte glucose uptake |
PMID:
19117549
|
Pparg+|Ppargtm1Mae |
Ppargtm1Mae/Pparg+ involves: 129S6/SvEvTac * C57BL/6 |
MGI:97747 |
MP:0000013 |
abnormal adipose tissue distribution |
PMID:
15254591
|
Pparg+|Ppargtm1Avp |
Ppargtm1Avp/Pparg+ involves: 129S2/SvPas * C57BL/6 |
MGI:97747 |
MP:0000013 |
abnormal adipose tissue distribution |
PMID:
17003330
|
Ppargtm2Avp |
Ppargtm2Avp/Ppargtm2Avp Not Specified |
MGI:97747 |
MP:0000013 |
abnormal adipose tissue distribution |
PMID:
15919792
|
Pparg+|Ppargtm1Lja |
Ppargtm1Lja/Pparg+ involves: 129S1/Sv * 129X1/SvJ |
MGI:97747 |
MP:0000003 |
abnormal adipose tissue morphology |
PMID:
15716267
|
Ppargtm1.2Mtz|Tg(Fabp4-cre/ERT2)1Ipc |
Ppargtm1.2Mtz/Ppargtm1.2Mtz,Tg(Fabp4-cre/ERT2)1Ipc/0 involves: C57BL/6 |
MGI:2450254
MGI:97747 |
MP:0005666 |
abnormal adipose tissue physiology |
PMID:
15070754
|
Pparg+|Ppargtm1Tka |
Ppargtm1Tka/Pparg+ involves: C57BL/6 * CBA * ICR |
MGI:97747 |
MP:0002459 |
abnormal B cell physiology |
PMID:
10549291
|
Atp2b2m1Mae|Ppargtm2Mae |
Atp2b2m1Mae/Atp2b2m1Mae,Ppargtm2Mae/Ppargtm2Mae involves: 129S6/SvEvTac * C57BL/6J |
MGI:105368
MGI:97747 |
MP:0001993 |
abnormal blinking |
PMID:
16845470
|
Ppargtm1Auw |
Ppargtm1Auw/Ppargtm1Auw either: 129/Sv or C57BL/6J or (involves: 129/Sv * C57BL/6J) |
MGI:97747 |
MP:0001777 |
abnormal body temperature regulation |
PMID:
14603033
|
Pparg+|Ppargtm1Tka |
Ppargtm1Tka/Pparg+ involves: C57BL/6 * CBA |
MGI:97747 |
MP:0000168 |
abnormal bone marrow development |
PMID:
15067317
|
Pparg+|Ppargtm1Tka |
Ppargtm1Tka/Pparg+ involves: C57BL/6 * CBA |
MGI:97747 |
MP:0002397 |
abnormal bone marrow morphology |
PMID:
15067317
|
Pparg+|Ppargtm1Tka |
Ppargtm1Tka/Pparg+ involves: C57BL/6 * CBA |
MGI:97747 |
MP:0008271 |
abnormal bone ossification |
PMID:
15067317
|
Ppargtm1.1Auw |
Ppargtm1.1Auw/Ppargtm1.1Auw B6.Cg-Pparg |
MGI:97747 |
MP:0003795 |
abnormal bone structure |
PMID:
19117549
|
Ppargtm2Rev|Tg(Fabp4-cre)1Rev |
Ppargtm2Rev/Ppargtm2Rev,Tg(Fabp4-cre)1Rev/? involves: 129S4/SvJae * C57BL/6 |
MGI:2450253
MGI:97747 |
MP:0002971 |
abnormal brown adipose tissue morphology |
PMID:
14660788
|
Ppargtm1Yec |
Ppargtm1Yec/Ppargtm1Yec involves: 129S4/SvJae * C57BL/6 |
MGI:97747 |
MP:0002971 |
abnormal brown adipose tissue morphology |
PMID:
15249658
|
Pparg+|Ppargtm2Yba |
Ppargtm2Yba/Pparg+ involves: 129S1/SvImJ * C57BL/6 |
MGI:97747 |
MP:0002971 |
abnormal brown adipose tissue morphology |
PMID:
17921248
|
Pparg+|Ppargtm3Yba |
Ppargtm3Yba/Pparg+ involves: 129S1/SvImJ * C57BL/6 |
MGI:97747 |
MP:0002971 |
abnormal brown adipose tissue morphology |
PMID:
17921248
|
Ppargtm1.2Mtz|Tg(Fabp4-cre/ERT2)1Ipc |
Ppargtm1.2Mtz/Ppargtm1.2Mtz,Tg(Fabp4-cre/ERT2)1Ipc/0 involves: C57BL/6 |
MGI:2450254
MGI:97747 |
MP:0009116 |
abnormal brown fat cell morphology |
PMID:
15070754
|
Pparg+|Ppargtm1Lja |
Ppargtm1Lja/Pparg+ involves: 129S1/Sv * 129X1/SvJ |
MGI:97747 |
MP:0009116 |
abnormal brown fat cell morphology |
PMID:
15716267
|
Pparg+|Ppargtm3Yba |
Ppargtm3Yba/Pparg+ involves: 129S1/SvImJ * C57BL/6 |
MGI:97747 |
MP:0009116 |
abnormal brown fat cell morphology |
PMID:
17921248
|
Ppargtm2Rev|Tg(Fabp4-cre)1Rev |
Ppargtm2Rev/Ppargtm2Rev,Tg(Fabp4-cre)1Rev/? involves: 129S4/SvJae * C57BL/6 |
MGI:2450253
MGI:97747 |
MP:0009135 |
abnormal brown fat cell size |
PMID:
14660788
|
Pparg+|Ppargtm1Tka |
Ppargtm1Tka/Pparg+ involves: C57BL/6 * CBA |
MGI:97747 |
MP:0000130 |
abnormal cancellous bone morphology |
PMID:
15067317
|
Ppargtm1Tka |
Ppargtm1Tka/Ppargtm1Tka involves: C57BL/6 * CBA |
MGI:97747 |
MP:0005076 |
abnormal cell differentiation |
PMID:
10549291
15067317
|
Pparg+|Ppargtm1Tka |
Ppargtm1Tka/Pparg+ involves: C57BL/6 * CBA |
MGI:97747 |
MP:0005076 |
abnormal cell differentiation |
PMID:
10549291
|
Ppargtm1.1Auw |
Ppargtm1.1Auw/Ppargtm1.1Auw B6.Cg-Pparg |
MGI:97747 |
MP:0005076 |
abnormal cell differentiation |
PMID:
19117549
|
Ppargtm1Rev |
Ppargtm1Rev/Ppargtm1Rev involves: 129S4/SvJae |
MGI:97747 |
MP:0004560 |
abnormal chorionic plate morphology |
PMID:
10549290
|
Ppargtm1Auw |
Ppargtm1Auw/Ppargtm1Auw either: 129/Sv or C57BL/6J or (involves: 129/Sv * C57BL/6J) |
MGI:97747 |
MP:0001573 |
abnormal circulating alanine transaminase level |
PMID:
14603033
|
Pparg+|Ppargtm1Mae |
Ppargtm1Mae/Pparg+ involves: 129S6/SvEvTac * C57BL/6 |
MGI:97747 |
MP:0009165 |
abnormal endocrine pancreas morphology |
PMID:
15254591
|
Pparg+|Ppargtm1Mae |
Ppargtm1Mae/Pparg+ involves: 129S6/SvEvTac * C57BL/6 |
MGI:97747 |
MP:0009115 |
abnormal fat cell morphology |
PMID:
15254591
|
Pparg+|Ppargtm1Avp |
Ppargtm1Avp/Pparg+ involves: 129S2/SvPas * C57BL/6 |
MGI:97747 |
MP:0009115 |
abnormal fat cell morphology |
PMID:
17003330
|
Lepob|Ppargtm2Avp |
Lepob/Lepob,Ppargtm2Avp/Ppargtm2Avp involves: 129/Sv * C57BL/6 |
MGI:104663
MGI:97747 |
MP:0009115 |
abnormal fat cell morphology |
PMID:
17465682
|
Ppargtm1Laz |
Ppargtm1Laz/Ppargtm1Laz involves: 129S6/SvEvTac * C57BL/6 |
MGI:97747 |
MP:0009115 |
abnormal fat cell morphology |
PMID:
14536066
|
Dok1tm1Yyam|Ppargtm1Laz |
Dok1tm1Yyam/Dok1tm1Yyam,Ppargtm1Laz/Ppargtm1Laz involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 |
MGI:893587
MGI:97747 |
MP:0009115 |
abnormal fat cell morphology |
PMID:
18204460
|
Pparg+|Ppargtm1Tka |
Ppargtm1Tka/Pparg+ involves: C57BL/6 * CBA |
MGI:97747 |
MP:0009115 |
abnormal fat cell morphology |
PMID:
10549291
15067317
|
Ppargtm1Rev |
Ppargtm1Rev/Ppargtm1Rev involves: 129S4/SvJae |
MGI:97747 |
MP:0008788 |
abnormal fetal cardiomyocyte morphology |
PMID:
10549290
|
Atp2b2m1Mae|Ppargtm2Mae |
Atp2b2m1Mae/Atp2b2m1Mae,Ppargtm2Mae/Ppargtm2Mae involves: 129S6/SvEvTac * C57BL/6J |
MGI:105368
MGI:97747 |
MP:0001406 |
abnormal gait |
PMID:
16845470
|
Pparg+|Ppargtm1Rev |
Ppargtm1Rev/Pparg+ involves: 129S4/SvJae * C57BL/6J |
MGI:97747 |
MP:0002078 |
abnormal glucose homeostasis |
PMID:
10675354
|
Ppargtm1Auw |
Ppargtm1Auw/Ppargtm1Auw either: 129/Sv or C57BL/6J or (involves: 129/Sv * C57BL/6J) |
MGI:97747 |
MP:0002078 |
abnormal glucose homeostasis |
PMID:
14603033
|
Lepob|Pparg+|Ppargtm1Avp |
Lepob/Lepob,Ppargtm1Avp/Pparg+ involves: 129S2/SvPas * C57BL/6 |
MGI:104663
MGI:97747 |
MP:0002078 |
abnormal glucose homeostasis |
PMID:
17003330
|
Ppargtm2Avp |
Ppargtm2Avp/Ppargtm2Avp Not Specified |
MGI:97747 |
MP:0002078 |
abnormal glucose homeostasis |
PMID:
15919792
|
Lepob|Ppargtm2Avp |
Lepob/Lepob,Ppargtm2Avp/Ppargtm2Avp involves: 129/Sv * C57BL/6 |
MGI:104663
MGI:97747 |
MP:0002078 |
abnormal glucose homeostasis |
PMID:
17465682
|
Ppargtm1Laz |
Ppargtm1Laz/Ppargtm1Laz involves: 129S6/SvEvTac * C57BL/6 |
MGI:97747 |
MP:0002078 |
abnormal glucose homeostasis |
PMID:
14536066
|
Pparg+|Ppargtm1Mae |
Ppargtm1Mae/Pparg+ involves: 129S6/SvEvTac * C57BL/6 |
MGI:97747 |
MP:0005335 |
abnormal gonadal fat pad morphology |
PMID:
15254591
|
Lepob|Pparg+|Ppargtm1Avp |
Lepob/Lepob,Ppargtm1Avp/Pparg+ involves: 129S2/SvPas * C57BL/6 |
MGI:104663
MGI:97747 |
MP:0005335 |
abnormal gonadal fat pad morphology |
PMID:
17003330
|
Ppargtm1Tka |
Ppargtm1Tka/Ppargtm1Tka involves: C57BL/6 * CBA |
MGI:97747 |
MP:0000267 |
abnormal heart development |
PMID:
10549291
|
Pparg+|Ppargtm2Yba |
Ppargtm2Yba/Pparg+ involves: 129S1/SvImJ * C57BL/6 |
MGI:97747 |
MP:0000607 |
abnormal hepatocyte morphology |
PMID:
17921248
|
Pparg+|Ppargtm1Tka |
Ppargtm1Tka/Pparg+ involves: C57BL/6 * CBA * ICR |
MGI:97747 |
MP:0001800 |
abnormal humoral immune response |
PMID:
10549291
|
Pparg+|Ppargtm1Mae |
Ppargtm1Mae/Pparg+ involves: 129S6/SvEvTac * C57BL/6 |
MGI:97747 |
MP:0005336 |
abnormal inguinal fat pad morphology |
PMID:
15254591
|
Lepob|Ppargtm2Avp |
Lepob/Lepob,Ppargtm2Avp/Ppargtm2Avp involves: 129/Sv * C57BL/6 |
MGI:104663
MGI:97747 |
MP:0003564 |
abnormal insulin secretion |
PMID:
17465682
|
Ppargtm1.2Mtz|Tg(Krt1-10-cre)1Pcn |
Ppargtm1.2Mtz/Ppargtm1.2Mtz,Tg(Krt1-10-cre)1Pcn/0 involves: C57BL/6 * SJL |
MGI:3629071
MGI:97747 |
MP:0002655 |
abnormal keratinocyte morphology |
PMID:
16751185
|
Pparg+|Ppargtm1Avp |
Ppargtm1Avp/Pparg+ involves: 129S2/SvPas * C57BL/6 |
MGI:97747 |
MP:0002118 |
abnormal lipid homeostasis |
PMID:
17003330
|
Lepob|Ppargtm2Avp |
Lepob/Lepob,Ppargtm2Avp/Ppargtm2Avp involves: 129/Sv * C57BL/6 |
MGI:104663
MGI:97747 |
MP:0002118 |
abnormal lipid homeostasis |
PMID:
17465682
|
Lepob|Ppargtm2Avp |
Lepob/Lepob,Ppargtm2Avp/Ppargtm2Avp involves: 129/Sv * C57BL/6 |
MGI:104663
MGI:97747 |
MP:0000598 |
abnormal liver morphology |
PMID:
17465682
|
Lepob|Ppargtm2Avp |
Lepob/Lepob,Ppargtm2Avp/Ppargtm2Avp involves: 129/Sv * C57BL/6 |
MGI:104663
MGI:97747 |
MP:0001392 |
abnormal locomotor activity |
PMID:
17465682
|
Ppargtm1.1Gonz|Tg(Mx1-cre)1Cgn |
Ppargtm1.1Gonz/Ppargtm1.1Gonz,Tg(Mx1-cre)1Cgn/? involves: 129X1/SvJ * C57BL/6 * CBA * FVB/N |
MGI:2176072
MGI:97747 |
MP:0002451 |
abnormal macrophage physiology |
PMID:
11909955
|
Ppargtm1Gonz|Tg(MMTV-cre)1Mam |
Ppargtm1Gonz/Ppargtm1Gonz,Tg(MMTV-cre)1Mam/? involves: 129X1/SvJ * FVB |
MGI:2176162
MGI:97747 |
MP:0006269 |
abnormal mammary gland growth during pregnancy |
PMID:
11884400
|
Atp2b2m1Mae|Ppargtm2Mae |
Atp2b2m1Mae/Atp2b2m1Mae,Ppargtm2Mae/Ppargtm2Mae involves: 129S6/SvEvTac * C57BL/6J |
MGI:105368
MGI:97747 |
MP:0001516 |
abnormal motor coordination/ balance |
PMID:
16845470
|
Pparg+|Ppargtm1Lja |
Ppargtm1Lja/Pparg+ involves: 129S1/Sv * 129X1/SvJ |
MGI:97747 |
MP:0004130 |
abnormal muscle cell glucose uptake |
PMID:
15716267
|
Ppargtm1Rev |
Ppargtm1Rev/Ppargtm1Rev involves: 129S4/SvJae |
MGI:97747 |
MP:0000278 |
abnormal myocardial fiber morphology |
PMID:
10549290
|
Ppargtm1Rev |
Ppargtm1Rev/Ppargtm1Rev involves: 129S4/SvJae |
MGI:97747 |
MP:0002189 |
abnormal myocardial trabeculae morphology |
PMID:
10549290
|
Pparg+|Ppargtm1Tka |
Ppargtm1Tka/Pparg+ involves: C57BL/6 * CBA |
MGI:97747 |
MP:0008395 |
abnormal osteoblast differentiation |
PMID:
15067317
|
Lepob|Ppargtm2Avp |
Lepob/Lepob,Ppargtm2Avp/Ppargtm2Avp involves: 129/Sv * C57BL/6 |
MGI:104663
MGI:97747 |
MP:0005215 |
abnormal pancreatic islet morphology |
PMID:
17465682
|
Ppargtm2Avp |
Ppargtm2Avp/Ppargtm2Avp involves: 129/Sv * C57BL/6 |
MGI:97747 |
MP:0005215 |
abnormal pancreatic islet morphology |
PMID:
17465682
|
Ppargtm1.1Mtz |
Ppargtm1.1Mtz/Ppargtm1.1Mtz involves: C57BL/6 |
MGI:97747 |
MP:0001712 |
abnormal placenta development |
PMID:
15070754
|
Ppargtm1Rev |
Ppargtm1Rev/Ppargtm1Rev involves: 129S4/SvJae |
MGI:97747 |
MP:0001716 |
abnormal placenta labyrinth morphology |
PMID:
10549290
|
Ppargtm1Tka |
Ppargtm1Tka/Ppargtm1Tka involves: C57BL/6 * CBA |
MGI:97747 |
MP:0001716 |
abnormal placenta labyrinth morphology |
PMID:
10549291
|
Ppargtm1Rev |
Ppargtm1Rev/Ppargtm1Rev involves: 129S4/SvJae |
MGI:97747 |
MP:0008803 |
abnormal placental labyrinth vasculature morphology |
PMID:
10549290
|
Ppargtm1Tka |
Ppargtm1Tka/Ppargtm1Tka involves: C57BL/6 * CBA |
MGI:97747 |
MP:0008803 |
abnormal placental labyrinth vasculature morphology |
PMID:
10549291
|
Ppargtm1Rev |
Ppargtm1Rev/Ppargtm1Rev involves: 129S4/SvJae |
MGI:97747 |
MP:0001711 |
abnormal placenta morphology |
PMID:
10549290
|
Atp2b2m1Mae|Ppargtm2Mae |
Atp2b2m1Mae/Atp2b2m1Mae,Ppargtm2Mae/Ppargtm2Mae involves: 129S6/SvEvTac * C57BL/6J |
MGI:105368
MGI:97747 |
MP:0003088 |
abnormal prepulse inhibition |
PMID:
16845470
|
Atp2b2+|Atp2b2m1Mae|Pparg+|Ppargtm2Mae |
Atp2b2m1Mae/Atp2b2+,Ppargtm2Mae/Pparg+ involves: 129S6/SvEvTac * C57BL/6J |
MGI:105368
MGI:97747 |
MP:0003088 |
abnormal prepulse inhibition |
PMID:
16845470
|
Atp2b2m1Mae|Ppargtm2Mae |
Atp2b2m1Mae/Atp2b2m1Mae,Ppargtm2Mae/Ppargtm2Mae involves: 129S6/SvEvTac * C57BL/6J |
MGI:105368
MGI:97747 |
MP:0001961 |
abnormal reflex |
PMID:
16845470
|
Pparg+|Ppargtm1Tka |
Ppargtm1Tka/Pparg+ involves: C57BL/6 * CBA |
MGI:97747 |
MP:0005164 |
abnormal response to injury |
PMID:
11889020
|
Pparg+|Ppargtm1Tka |
Ppargtm1Tka/Pparg+ involves: C57BL/6 * CBA * ICR |
MGI:97747 |
MP:0005164 |
abnormal response to injury |
PMID:
11159886
|
Pparg+|Ppargtm1Tka |
Ppargtm1Tka/Pparg+ involves: C57BL/6 * CBA |
MGI:97747 |
MP:0002792 |
abnormal retinal vasculature morphology |
PMID:
17003451
|
Lepob|Pparg+|Ppargtm1Avp |
Lepob/Lepob,Ppargtm1Avp/Pparg+ involves: 129S2/SvPas * C57BL/6 |
MGI:104663
MGI:97747 |
MP:0000759 |
abnormal skeletal muscle morphology |
PMID:
17003330
|
Lepob|Ppargtm2Avp |
Lepob/Lepob,Ppargtm2Avp/Ppargtm2Avp involves: 129/Sv * C57BL/6 |
MGI:104663
MGI:97747 |
MP:0000759 |
abnormal skeletal muscle morphology |
PMID:
17465682
|
Ppargtm1.2Mtz|Tg(Krt1-10-cre)1Pcn |
Ppargtm1.2Mtz/Ppargtm1.2Mtz,Tg(Krt1-10-cre)1Pcn/0 involves: C57BL/6 * SJL |
MGI:3629071
MGI:97747 |
MP:0002060 |
abnormal skin morphology |
PMID:
16751185
|
Pparg+|Ppargtm1Avp |
Ppargtm1Avp/Pparg+ involves: 129S2/SvPas * C57BL/6 |
MGI:97747 |
MP:0000187 |
abnormal triglyceride level |
PMID:
17003330
|
Ppargtm1Rev |
Ppargtm1Rev/Ppargtm1Rev involves: 129S4/SvJae |
MGI:97747 |
MP:0005033 |
abnormal trophoblast giant cells |
PMID:
10549290
|
Ppargtm1Rev |
Ppargtm1Rev/Ppargtm1Rev involves: 129S4/SvJae |
MGI:97747 |
MP:0005031 |
abnormal trophoblast layer morphology |
PMID:
10549290
|
Atp2b2m1Mae|Ppargtm2Mae |
Atp2b2m1Mae/Atp2b2m1Mae,Ppargtm2Mae/Ppargtm2Mae involves: 129S6/SvEvTac * C57BL/6J |
MGI:105368
MGI:97747 |
MP:0001490 |
abnormal vibrissae reflex |
PMID:
16845470
|
Atp2b2m1Mae|Ppargtm2Mae |
Atp2b2m1Mae/Atp2b2m1Mae,Ppargtm2Mae/Ppargtm2Mae involves: 129S6/SvEvTac * C57BL/6J |
MGI:105368
MGI:97747 |
MP:0003491 |
abnormal voluntary movement |
PMID:
16845470
|
Ppargtm2Rev|Tg(Fabp4-cre)1Rev |
Ppargtm2Rev/Ppargtm2Rev,Tg(Fabp4-cre)1Rev/? involves: 129S4/SvJae * C57BL/6 |
MGI:2450253
MGI:97747 |
MP:0001781 |
abnormal white adipose tissue amount |
PMID:
14660788
|
Lepob|Pparg+|Ppargtm1Avp |
Lepob/Lepob,Ppargtm1Avp/Pparg+ involves: 129S2/SvPas * C57BL/6 |
MGI:104663
MGI:97747 |
MP:0001781 |
abnormal white adipose tissue amount |
PMID:
17003330
|
Ppargtm1Yec |
Ppargtm1Yec/Ppargtm1Yec involves: 129S4/SvJae * C57BL/6 |
MGI:97747 |
MP:0002970 |
abnormal white adipose tissue morphology |
PMID:
15249658
|
Pparg+|Ppargtm1Lja |
Ppargtm1Lja/Pparg+ involves: 129S1/Sv * 129X1/SvJ |
MGI:97747 |
MP:0002970 |
abnormal white adipose tissue morphology |
PMID:
15716267
|
Pparg+|Ppargtm2Yba |
Ppargtm2Yba/Pparg+ involves: 129S1/SvImJ * C57BL/6 |
MGI:97747 |
MP:0002970 |
abnormal white adipose tissue morphology |
PMID:
17921248
|
Ppargtm1Yec |
Ppargtm1Yec/Ppargtm1Yec involves: 129S4/SvJae * C57BL/6 |
MGI:97747 |
MP:0005670 |
abnormal white adipose tissue physiology |
PMID:
15249658
|
Ppargtm2Avp |
Ppargtm2Avp/Ppargtm2Avp Not Specified |
MGI:97747 |
MP:0005670 |
abnormal white adipose tissue physiology |
PMID:
15919792
|
Ppargtm1.2Mtz|Tg(Fabp4-cre/ERT2)1Ipc |
Ppargtm1.2Mtz/Ppargtm1.2Mtz,Tg(Fabp4-cre/ERT2)1Ipc/0 involves: C57BL/6 |
MGI:2450254
MGI:97747 |
MP:0009117 |
abnormal white fat cell morphology |
PMID:
15070754
|
Pparg+|Ppargtm2Yba |
Ppargtm2Yba/Pparg+ involves: 129S1/SvImJ * C57BL/6 |
MGI:97747 |
MP:0009117 |
abnormal white fat cell morphology |
PMID:
17921248
|
Pparg+|Ppargtm2Yba |
Ppargtm2Yba/Pparg+ involves: 129S1/SvImJ * C57BL/6 |
MGI:97747 |
MP:0009132 |
abnormal white fat cell size |
PMID:
17921248
|
Atp2b2m1Mae|Ppargtm2Mae |
Atp2b2m1Mae/Atp2b2m1Mae,Ppargtm2Mae/Ppargtm2Mae involves: 129S6/SvEvTac * C57BL/6J |
MGI:105368
MGI:97747 |
MP:0006358 |
absent pinna reflex |
PMID:
16845470
|
Atp2b2m1Mae|Ppargtm2Mae |
Atp2b2m1Mae/Atp2b2m1Mae,Ppargtm2Mae/Ppargtm2Mae involves: 129S6/SvEvTac * C57BL/6J |
MGI:105368
MGI:97747 |
MP:0006359 |
absent startle reflex |
PMID:
16845470
|
Pparg+|Ppargtm2Yba |
Ppargtm2Yba/Pparg+ involves: 129S1/SvImJ * C57BL/6 |
MGI:97747 |
MP:0008843 |
absent subcutaneous adipose tissue |
PMID:
17921248
|
Atp2b2m1Mae|Ppargtm2Mae |
Atp2b2m1Mae/Atp2b2m1Mae,Ppargtm2Mae/Ppargtm2Mae involves: 129S6/SvEvTac * C57BL/6J |
MGI:105368
MGI:97747 |
MP:0001393 |
ataxia |
PMID:
16845470
|
Ppargtm1.1Gonz|Tg(Myhca-cre)1Abel |
Ppargtm1.1Gonz/Ppargtm1.1Gonz,Tg(Myhca-cre)1Abel/0 involves: 129X1/SvJ * FVB |
MGI:2182090
MGI:97747 |
MP:0001625 |
cardiac hypertrophy |
PMID:
16051889
|
Ppargtm1Yec |
Ppargtm1Yec/Ppargtm1Yec involves: 129S4/SvJae * C57BL/6 |
MGI:97747 |
MP:0004893 |
decreased adiponectin level |
PMID:
15249658
|
Pparg+|Ppargtm1Lja |
Ppargtm1Lja/Pparg+ involves: 129S1/Sv * 129X1/SvJ |
MGI:97747 |
MP:0004893 |
decreased adiponectin level |
PMID:
15716267
|
Pparg+|Ppargtm1Avp |
Ppargtm1Avp/Pparg+ involves: 129S2/SvPas * C57BL/6 |
MGI:97747 |
MP:0004893 |
decreased adiponectin level |
PMID:
17003330
|
Lepob|Pparg+|Ppargtm1Avp |
Lepob/Lepob,Ppargtm1Avp/Pparg+ involves: 129S2/SvPas * C57BL/6 |
MGI:104663
MGI:97747 |
MP:0004893 |
decreased adiponectin level |
PMID:
17003330
|
Ppargtm2Avp |
Ppargtm2Avp/Ppargtm2Avp Not Specified |
MGI:97747 |
MP:0004893 |
decreased adiponectin level |
PMID:
15919792
|
Lepob|Ppargtm2Avp |
Lepob/Lepob,Ppargtm2Avp/Ppargtm2Avp involves: 129/Sv * C57BL/6 |
MGI:104663
MGI:97747 |
MP:0004893 |
decreased adiponectin level |
PMID:
17465682
|
Ppargtm2Avp |
Ppargtm2Avp/Ppargtm2Avp involves: 129/Sv * C57BL/6 |
MGI:97747 |
MP:0004893 |
decreased adiponectin level |
PMID:
17465682
|
Ppargtm1.1Auw |
Ppargtm1.1Auw/Ppargtm1.1Auw B6.Cg-Pparg |
MGI:97747 |
MP:0006086 |
decreased body mass index |
PMID:
19117549
|
Atp2b2m1Mae|Ppargtm2Mae |
Atp2b2m1Mae/Atp2b2m1Mae,Ppargtm2Mae/Ppargtm2Mae involves: 129S6/SvEvTac * C57BL/6J |
MGI:105368
MGI:97747 |
MP:0001265 |
decreased body size |
PMID:
16845470
|
Ppargtm1Auw |
Ppargtm1Auw/Ppargtm1Auw either: 129/Sv or C57BL/6J or (involves: 129/Sv * C57BL/6J) |
MGI:97747 |
MP:0001262 |
decreased body weight |
PMID:
14603033
|
Ppargtm1Yec |
Ppargtm1Yec/Ppargtm1Yec involves: 129S4/SvJae * C57BL/6 |
MGI:97747 |
MP:0001262 |
decreased body weight |
PMID:
15249658
|
Pparg+|Ppargtm1Lja |
Ppargtm1Lja/Pparg+ involves: 129S1/Sv * 129X1/SvJ |
MGI:97747 |
MP:0001262 |
decreased body weight |
PMID:
15716267
|
Lepob|Pparg+|Ppargtm1Avp |
Lepob/Lepob,Ppargtm1Avp/Pparg+ involves: 129S2/SvPas * C57BL/6 |
MGI:104663
MGI:97747 |
MP:0001262 |
decreased body weight |
PMID:
17003330
|
Ppargtm1.1Auw |
Ppargtm1.1Auw/Ppargtm1.1Auw B6.Cg-Pparg |
MGI:97747 |
MP:0001262 |
decreased body weight |
PMID:
19117549
|
Ppargtm1Auw |
Ppargtm1Auw/Ppargtm1Auw either: 129/Sv or C57BL/6J or (involves: 129/Sv * C57BL/6J) |
MGI:97747 |
MP:0001780 |
decreased brown adipose tissue amount |
PMID:
14603033
|
Ppargtm2Rev|Tg(Fabp4-cre)1Rev |
Ppargtm2Rev/Ppargtm2Rev,Tg(Fabp4-cre)1Rev/? involves: 129S4/SvJae * C57BL/6 |
MGI:2450253
MGI:97747 |
MP:0001780 |
decreased brown adipose tissue amount |
PMID:
14660788
|
Ppargtm1.2Mtz|Tg(Fabp4-cre/ERT2)1Ipc |
Ppargtm1.2Mtz/Ppargtm1.2Mtz,Tg(Fabp4-cre/ERT2)1Ipc/0 involves: C57BL/6 |
MGI:2450254
MGI:97747 |
MP:0001780 |
decreased brown adipose tissue amount |
PMID:
15070754
|
Pparg+|Ppargtm1Tka |
Ppargtm1Tka/Pparg+ involves: C57BL/6 * CBA |
MGI:97747 |
MP:0001780 |
decreased brown adipose tissue amount |
PMID:
10549291
|
Ppargtm1Yec |
Ppargtm1Yec/Ppargtm1Yec involves: 129S4/SvJae * C57BL/6 |
MGI:97747 |
MP:0009125 |
decreased brown fat cell lipid droplet size |
PMID:
15249658
|
Ppargtm2Rev|Tg(Fabp4-cre)1Rev |
Ppargtm2Rev/Ppargtm2Rev,Tg(Fabp4-cre)1Rev/? involves: 129S4/SvJae * C57BL/6 |
MGI:2450253
MGI:97747 |
MP:0009128 |
decreased brown fat cell number |
PMID:
14660788
|
Ppargtm1Yec |
Ppargtm1Yec/Ppargtm1Yec involves: 129S4/SvJae * C57BL/6 |
MGI:97747 |
MP:0009137 |
decreased brown fat lipid droplet number |
PMID:
15249658
|
Ppargtm1.1Auw |
Ppargtm1.1Auw/Ppargtm1.1Auw B6.Cg-Pparg |
MGI:97747 |
MP:0005179 |
decreased circulating cholesterol level |
PMID:
19117549
|
Ppargtm1Laz |
Ppargtm1Laz/Ppargtm1Laz involves: 129S6/SvEvTac * C57BL/6 |
MGI:97747 |
MP:0002702 |
decreased circulating free fatty acid level |
PMID:
14536066
|
Lepob|Ppargtm2Avp |
Lepob/Lepob,Ppargtm2Avp/Ppargtm2Avp involves: 129/Sv * C57BL/6 |
MGI:104663
MGI:97747 |
MP:0002727 |
decreased circulating insulin level |
PMID:
17465682
|
Pparg+|Ppargtm1Tka |
Ppargtm1Tka/Pparg+ involves: C57BL/6 * CBA |
MGI:97747 |
MP:0002727 |
decreased circulating insulin level |
PMID:
10549291
|
Ppargtm1Yec |
Ppargtm1Yec/Ppargtm1Yec involves: 129S4/SvJae * C57BL/6 |
MGI:97747 |
MP:0005668 |
decreased circulating leptin level |
PMID:
15249658
|
Ppargtm1Laz |
Ppargtm1Laz/Ppargtm1Laz involves: 129S6/SvEvTac * C57BL/6 |
MGI:97747 |
MP:0005668 |
decreased circulating leptin level |
PMID:
14536066
|
Ppargtm1Laz |
Ppargtm1Laz/Ppargtm1Laz involves: 129S6/SvEvTac * C57BL/6 |
MGI:97747 |
MP:0002644 |
decreased circulating triglyceride level |
PMID:
14536066
|
Ppargtm1.1Auw |
Ppargtm1.1Auw/Ppargtm1.1Auw B6.Cg-Pparg |
MGI:97747 |
MP:0002644 |
decreased circulating triglyceride level |
PMID:
19117549
|
Pparg+|Ppargtm1Tka |
Ppargtm1Tka/Pparg+ involves: C57BL/6 * CBA |
MGI:97747 |
MP:0003910 |
decreased eating behavior |
PMID:
10549291
|
Ppargtm1Lja |
Ppargtm1Lja/Ppargtm1Lja involves: 129S1/Sv * 129X1/SvJ |
MGI:97747 |
MP:0001698 |
decreased embryo size |
PMID:
15716267
|
Ppargtm1.2Mtz|Tg(Fabp4-cre/ERT2)1Ipc |
Ppargtm1.2Mtz/Ppargtm1.2Mtz,Tg(Fabp4-cre/ERT2)1Ipc/0 involves: C57BL/6 |
MGI:2450254
MGI:97747 |
MP:0009289 |
decreased epididymal fat pad weight |
PMID:
15070754
|
Lepob|Pparg+|Ppargtm1Avp |
Lepob/Lepob,Ppargtm1Avp/Pparg+ involves: 129S2/SvPas * C57BL/6 |
MGI:104663
MGI:97747 |
MP:0009269 |
decreased fat cell size |
PMID:
17003330
|
Ppargtm1Yec |
Ppargtm1Yec/Ppargtm1Yec involves: 129S4/SvJae * C57BL/6 |
MGI:97747 |
MP:0009283 |
decreased gonadal fat pad weight |
PMID:
15249658
|
Pparg+|Ppargtm2Yba |
Ppargtm2Yba/Pparg+ involves: 129S1/SvImJ * C57BL/6 |
MGI:97747 |
MP:0009283 |
decreased gonadal fat pad weight |
PMID:
17921248
|
Pparg+|Ppargtm3Yba |
Ppargtm3Yba/Pparg+ involves: 129S1/SvImJ * C57BL/6 |
MGI:97747 |
MP:0009283 |
decreased gonadal fat pad weight |
PMID:
17921248
|
Atp2b2m1Mae|Ppargtm2Mae |
Atp2b2m1Mae/Atp2b2m1Mae,Ppargtm2Mae/Ppargtm2Mae involves: 129S6/SvEvTac * C57BL/6J |
MGI:105368
MGI:97747 |
MP:0010053 |
decreased grip strength |
PMID:
16845470
|
Ppargtm1.1Gonz|Tg(Myhca-cre)1Abel |
Ppargtm1.1Gonz/Ppargtm1.1Gonz,Tg(Myhca-cre)1Abel/0 involves: 129X1/SvJ * FVB |
MGI:2182090
MGI:97747 |
MP:0005333 |
decreased heart rate |
PMID:
16051889
|
Ppargtm1Yec |
Ppargtm1Yec/Ppargtm1Yec involves: 129S4/SvJae * C57BL/6 |
MGI:97747 |
MP:0009293 |
decreased inguinal fat pad weight |
PMID:
15249658
|
Ppargtm2Rev|Tg(Fabp4-cre)1Rev |
Ppargtm2Rev/Ppargtm2Rev,Tg(Fabp4-cre)1Rev/? involves: 129S4/SvJae * C57BL/6 |
MGI:2450253
MGI:97747 |
MP:0009295 |
decreased interscapular fat pad weight |
PMID:
14660788
|
Ppargtm1Gonz|Tg(MMTV-cre)1Mam |
Ppargtm1Gonz/Ppargtm1Gonz,Tg(MMTV-cre)1Mam/? involves: 129X1/SvJ * FVB |
MGI:2176162
MGI:97747 |
MP:0001935 |
decreased litter size |
PMID:
11884400
|
Lepob|Ppargtm2Avp |
Lepob/Lepob,Ppargtm2Avp/Ppargtm2Avp involves: 129/Sv * C57BL/6 |
MGI:104663
MGI:97747 |
MP:0009356 |
decreased liver triglyceride level |
PMID:
17465682
|
Ppargtm1.2Mtz|Tg(Fabp4-cre/ERT2)1Ipc |
Ppargtm1.2Mtz/Ppargtm1.2Mtz,Tg(Fabp4-cre/ERT2)1Ipc/0 involves: C57BL/6 |
MGI:2450254
MGI:97747 |
MP:0005459 |
decreased percent body fat |
PMID:
15070754
|
Lepob|Ppargtm2Avp |
Lepob/Lepob,Ppargtm2Avp/Ppargtm2Avp involves: 129/Sv * C57BL/6 |
MGI:104663
MGI:97747 |
MP:0010379 |
decreased respiratory quotient |
PMID:
17465682
|
Ppargtm1Yec |
Ppargtm1Yec/Ppargtm1Yec involves: 129S4/SvJae * C57BL/6 |
MGI:97747 |
MP:0009305 |
decreased retroperitoneal fat pad weight |
PMID:
15249658
|
Atp2b2+|Atp2b2m1Mae|Pparg+|Ppargtm2Mae |
Atp2b2m1Mae/Atp2b2+,Ppargtm2Mae/Pparg+ involves: 129S6/SvEvTac * C57BL/6J |
MGI:105368
MGI:97747 |
MP:0001489 |
decreased startle reflex |
PMID:
16845470
|
Pparg+|Ppargtm3Yba |
Ppargtm3Yba/Pparg+ involves: 129S1/SvImJ * C57BL/6 |
MGI:97747 |
MP:0008844 |
decreased subcutaneous adipose tissue amount |
PMID:
17921248
|
Ppargtm1.1Unc |
Ppargtm1.1Unc/Ppargtm1.1Unc involves: 129S6/SvEvTac * C57BL/6J |
MGI:97747 |
MP:0002843 |
decreased systemic arterial blood pressure |
PMID:
19884495
|
Pparg+|Ppargtm1.1Unc |
Ppargtm1.1Unc/Pparg+ involves: 129S6/SvEvTac * C57BL/6J |
MGI:97747 |
MP:0002843 |
decreased systemic arterial blood pressure |
PMID:
19884495
|
Pparg+|Ppargtm1Uls |
Ppargtm1Uls/Pparg+ involves: 129S2/SvPas * C57BL/6 |
MGI:97747 |
MP:0010025 |
decreased total body fat amount |
PMID:
15231871
|
Pparg+|Ppargtm1Lja |
Ppargtm1Lja/Pparg+ involves: 129S1/Sv * 129X1/SvJ |
MGI:97747 |
MP:0010025 |
decreased total body fat amount |
PMID:
15716267
|
Lepob|Pparg+|Ppargtm1Avp |
Lepob/Lepob,Ppargtm1Avp/Pparg+ involves: 129S2/SvPas * C57BL/6 |
MGI:104663
MGI:97747 |
MP:0010025 |
decreased total body fat amount |
PMID:
17003330
|
Ppargtm2Avp |
Ppargtm2Avp/Ppargtm2Avp Not Specified |
MGI:97747 |
MP:0010025 |
decreased total body fat amount |
PMID:
15919792
|
Pparg+|Ppargtm1Tka |
Ppargtm1Tka/Pparg+ involves: C57BL/6 * CBA |
MGI:97747 |
MP:0010025 |
decreased total body fat amount |
PMID:
10549291
|
Ppargtm1.1Auw |
Ppargtm1.1Auw/Ppargtm1.1Auw B6.Cg-Pparg |
MGI:97747 |
MP:0008907 |
decreased total fat pad weight |
PMID:
19117549
|
Lepob|Ppargtm2Avp |
Lepob/Lepob,Ppargtm2Avp/Ppargtm2Avp involves: 129/Sv * C57BL/6 |
MGI:104663
MGI:97747 |
MP:0005318 |
decreased triglyceride level |
PMID:
17465682
|
Ppargtm1Auw |
Ppargtm1Auw/Ppargtm1Auw either: 129/Sv or C57BL/6J or (involves: 129/Sv * C57BL/6J) |
MGI:97747 |
MP:0001783 |
decreased white adipose tissue amount |
PMID:
14603033
|
Ppargtm1Yec |
Ppargtm1Yec/Ppargtm1Yec involves: 129S4/SvJae * C57BL/6 |
MGI:97747 |
MP:0001783 |
decreased white adipose tissue amount |
PMID:
15249658
|
Pparg+|Ppargtm1Lja |
Ppargtm1Lja/Pparg+ involves: 129S1/Sv * 129X1/SvJ |
MGI:97747 |
MP:0001783 |
decreased white adipose tissue amount |
PMID:
15716267
|
Ppargtm1Yec |
Ppargtm1Yec/Ppargtm1Yec involves: 129S4/SvJae * C57BL/6 |
MGI:97747 |
MP:0009131 |
decreased white fat cell number |
PMID:
15249658
|
Ppargtm1Yec |
Ppargtm1Yec/Ppargtm1Yec involves: 129S4/SvJae * C57BL/6 |